JamesELiebmannMD

Oncology • Beverly, MA

Assistant Professor, Medicine, University Massachusetts Medical School

Join to view full profile

Dr. Liebmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Liebmann's full profile

Already have an account?

Office
85 Herrick St
Beverly, MA 01915
Phone+1 978-927-6850

Fax+1 978-524-7917
Is this information wrong?

Education & Training

University of WashingtonResidency, Internal Medicine, 1983 - 1986
University of California San Francisco School of MedicineClass of 1983
National Institutes of Health Clinical CenterFellowship, Medical Oncology

Certifications & Licensure

MA State Medical License 2008 - 2025
NM State Medical License 1994 - 2010
MD State Medical License 1989 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

8 citations
Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia.
Pallavi Galera, Stefanie Haynes, Paula Sulmasy, Jeffrey A. Bailey, Mindy Greene, Michelle Vauthrin, Doreen B. Brettler, James Liebmann, J. Mark Madison, Robert Weinstein> ;Journal of Clinical Apheresis. 2016 Aug 1
1 citations
The Diagnostic Utility of Tumor Markers: A Teachable Moment
Justin K. Lui, Adedotun Ogunsua, Steven C. Hatch, James Liebmann, Gail Scully> ;The American Journal of Medicine. 2015 May 1
15 citations
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study...
Tomasz P. Srokowski, James Liebmann, Manuel Modiano, Gary I. Cohen, Barbara Pro, Jorge E. Romaguera, Christine Kuepfer, Jack W. Singer, Luis Fayad> ;Cancer. 2011 Nov 15
40 citations
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.
Yehuda Z. Patt, Fa-Chyi Lee, James Liebmann, Dimitrios Diamandidis, S. Gail Eckhardt, Milind Javle, Glen R. Justice, Wayne Keiser, Joseph R. Salvatore, Alice Bexon, Ed...> ;American Journal of Clinical Oncology. 2007 Aug 1
A phase 1 study of weekly, divided dose perifosine in patients (pts) with non-small cell lung cancer (NSCLC).
Henderson IC, Spigel DR, Nemunaitis JJ, Richards DA, Liebmann JE, Purcell WT, Birch R, Gardner LR, Burris Iii HA> ;J. Clin. Oncol.. 2006-06-20
Thalidomide increases thrombin generation in multiple myeloma patients.
Candelaria D, Armijo B, Montgomery R, Lee F, Moll S, Garcia D, Liebmann J, Libby E> ;J. Clin. Oncol.. 2006-06-20
Phase II trial of R-CHOP plus maintenance rituximab for previously untreated intermediate or high grade non-Hodgkin's lymphoma (IHGNHL) with filgrastim support for old...
Desch C, Case D, Kalman L, Vongkovit P, Liebmann J, Fridman M, Allen B> ;J. Clin. Oncol.. 2005-06-01
Capecitabine (X) plus irinotecan (XELIRI) as first-line treatment for metastatic colorectal cancer (MCRC): Final safety findings from a phase II trial.
Patt YZ, Liebmann J, Diamandidis D, Eckhardt SG, Javle M, Justice GR, Keiser W, Lee FC, Miller W, Lin E> ;J. Clin. Oncol.. 2004-07-15
396 citations
Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase II...
Christina A. Meyers, Jennifer A. Smith, Andrea Bezjak, Minesh P. Mehta, James Liebmann, Timothy M Illidge, Ian Kunkler, Jean-Michel Caudrelier, Peter D. Eisenberg, J.H...> ;Journal of Clinical Oncology. 2004 Jan 1
63 citations
Hemodynamic effect of the nitroxide superoxide dismutase mimics.
Stephen M. Hahn, Francis J. Sullivan, Anne Marie DeLuca, John D Bacher, James Liebmann, Murali C. Krishna, Deborah Coffin, James B. Mitchell> ;Free Radical Biology & Medicine. 1999 Sep 1
56 citations
THE ROLE OF NITRIC OXIDE CHEMISTRY IN CANCER TREATMENT
David A. Wink, Yoram Vodovotz, John A. Cook, Murali C. Krishna, S Kim, D Coffin, William DeGraff, A M Deluca, James Liebmann, James Mitchell> ;Biochemistry. Biokhimiia. 1998 Jul 1
56 citations
Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines.
C Theodossiou, John A. Cook, Joyce M. Fisher, Diane Teague, James Liebmann, Angelo Russo, James B. Mitchell> ;International Journal of Oncology. 1998 Apr 1
26 citations
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer.
Laurie L. Herscher, Stephen M. Hahn, Glenn S. Kroog, Harvey I. Pass, Barbara K. Temeck, Barry R. Goldspiel, John A. Cook, James B. Mitchell, James Liebmann> ;Journal of Clinical Oncology. 1998 Feb 1
7 citations
Acute renal failure in a patient receiving treatment with suramin
Anthony Y. Smith, Darlene Harbour, James Liebmann> ;American Journal of Clinical Oncology. 1997 Aug 1
34 citations
Nitric oxide enhancement of melphalan-induced cytotoxicity.
John A. Cook, M. C. Krishna, R. Pacelli, William DeGraff, James Liebmann, James B. Mitchell, Angelo Russo, David A. Wink> ;British Journal of Cancer. 1997 Jan 1
1 citations
Adynamic ileus in a patientwith non-small-cell lung cancer after treatment with vinorelbine
James Liebmann, Kenneth Friedman> ;The American Journal of Medicine. 1996 Dec 1
166 citations
The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection.
David A. Wink, John A. Cook, Roberto Pacelli, William DeGraff, Janet Gamson, James Liebmann, Murali C. Krishna, James B. Mitchell> ;Archives of Biochemistry and Biophysics. 1996 Jul 15
7 citations
Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma
Barbara K. Temeck, James E. Liebmann, Christopher Theodossiou, Seth M. Steinberg, John A. Cook, David C. Metz, Thomas H. Shawker, Carmen J. Allegra, Angelo Russo, Harv...> ;Cancer. 1996 Jun 15
12 citations
Antagonism of paclitaxel cytotoxicity by X-rays.
James Liebmann, L Herscher, Joyce M. Fisher, Diane Teague, John A. Cook> ;International Journal of Oncology. 1996 May 1
207 citations
Chemical biology of nitric oxide: regulation and protective and toxic mechanisms.
David A. Wink, Ingeborg Hanbauer, Matthew B. Grisham, Francoise Laval, Raymond W. Nims, Jacques Laval, John A. Cook, Roberto Pacelli, James Liebmann, Murali C. Krishna...> ;Current Topics in Cellular Regulation. 1996 Jan 1
111 citations
Nitric oxide (NO) protects against cellular damage by reactive oxygen species
David A. Wink, John A. Cook, Roberto Pacelli, James Liebmann, Murali C. Krishna, James B. Mitchell> ;Toxicology Letters. 1995 Dec 1
22 citations
Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
James Liebmann, Joyce M. Fisher, Claudia A. Lipschultz, Richard Kuno, Dwight Kaufman> ;Cancer Research. 1995 Oct 1
1 citations
Combination intraventricular therapy with thiotepa and cytarabine in meningeal carcinomatosis due to breast cancer: in vitro evidence for supra-additive cytotoxicity.
James Liebmann, Jayne Gurtler> ;Anti-Cancer Drugs. 1995 Feb 1
45 citations
In Vivo Radiation Protection by Nitric Oxide Modulation
James Liebmann, Anne Marie DeLuca, Deborah Coffin, Larry K. Keefer, David Venzon, David A. Wink, James Mitchell> ;Cancer Research. 1994 Jul 1
73 citations
Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol).
James Liebmann, John A. Cook, Joyce M. Fisher, Diane Teague, James Mitchell> ;International Journal of Radiation Oncology, Biology, Physics. 1994 Jun 15
Join now to see all